📣 VC round data is live. Check it out!
- Public Comps
- Nakanishi
Nakanishi Valuation Multiples
Discover revenue and EBITDA valuation multiples for Nakanishi and similar public comparables like PROCEPT BioRobotics, Immunocore Holdings, Cofoe Medical, Weigao Group and more.
Nakanishi Overview
About Nakanishi
Nakanishi Inc manufactures high-speed rotary cutting technology for the dental industry and the medical industry more broadly. The company distributes its products to countries internationally, earning most of its revenue overseas. The company operates via three business segments. The dental product segment manufactures and sells handpieces for dental treatment, mechanical micro motors and handpieces as well as handpieces for surgeries. The industrial product segment manufactures and sells grinders for manual works and spindles for machinery attachment. The others segment provides inspection and repair services for its dental and medical equipment and general industrial cutting and grinding equipment.
Founded
1981
HQ

Employees
1.4K
Website
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialNakanishi Financials
Nakanishi reported last 12-month revenue of $547M and EBITDA of $135M.
In the same LTM period, Nakanishi generated $312M in gross profit, $135M in EBITDA, and $24M in net income.
Revenue (LTM)
Nakanishi P&L
In the most recent fiscal year, Nakanishi reported revenue of $530M and EBITDA of $130M.
Nakanishi is unprofitable as of last fiscal year, with gross margin of 54%, EBITDA margin of 25%, and net margin of (3%).
Financial data powered by Morningstar, Inc.
Nakanishi Stock Performance
Nakanishi has current market cap of $2B, and enterprise value of $1B.
Market Cap Evolution
Nakanishi's stock price is $18.24.
Nakanishi share price decreased by 4.7% in the last 30 days, and increased by 52.9% in the last year.
Nakanishi has an EPS (earnings per share) of $-0.18.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $2B | -4.8% | -4.7% | 7.2% | 52.9% | $-0.18 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNakanishi Valuation Multiples
Nakanishi trades at 2.4x EV/Revenue multiple, and 9.9x EV/EBITDA.
EV / Revenue (LTM)
Nakanishi Financial Valuation Multiples
As of June 4, 2026, Nakanishi has market cap of $2B and EV of $1B.
Nakanishi has a P/E ratio of 63.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nakanishi Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Nakanishi Margins & Growth Rates
Nakanishi grew revenue by 8% and EBITDA by 9% in the last fiscal year.
In the most recent fiscal year, Nakanishi reported gross margin of 54%, EBITDA margin of 25%, and net margin of (3%).
Nakanishi Margins
Nakanishi Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Nakanishi Operational KPIs
Nakanishi's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Nakanishi's Rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nakanishi's Rule of X is 55% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Nakanishi Competitors
Nakanishi competitors include PROCEPT BioRobotics, Immunocore Holdings, Cofoe Medical, Weigao Group, El.En. Group, Savaria, Haier Biomedical, BoneSupport, SKAN Group and Anbio Biotechnology.
Most Nakanishi public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.4x | 3.9x | (27.0x) | (34.2x) | |||
| 2.7x | 2.6x | (298.4x) | (47.1x) | |||
| 2.6x | 2.4x | 13.9x | 13.1x | |||
| 5.6x | 5.3x | 16.1x | 16.6x | |||
| 1.8x | 1.8x | 11.9x | 11.4x | |||
| 2.4x | 2.3x | 11.6x | 11.2x | |||
| 3.6x | 3.5x | 21.3x | 21.2x | |||
| 11.9x | 10.7x | 57.4x | 44.0x | |||
This data is available for Pro users. Sign up to see all Nakanishi competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nakanishi
| When was Nakanishi founded? | Nakanishi was founded in 1981. |
| Where is Nakanishi headquartered? | Nakanishi is headquartered in Japan. |
| How many employees does Nakanishi have? | As of today, Nakanishi has over 1K employees. |
| Who is the CEO of Nakanishi? | Nakanishi's CEO is Eiichi Nakanishi. |
| Is Nakanishi publicly listed? | Yes, Nakanishi is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Nakanishi? | Nakanishi trades under 7716 ticker. |
| When did Nakanishi go public? | Nakanishi went public in 2013. |
| Who are competitors of Nakanishi? | Nakanishi main competitors include PROCEPT BioRobotics, Immunocore Holdings, Cofoe Medical, Weigao Group, El.En. Group, Savaria, Haier Biomedical, BoneSupport, SKAN Group, Anbio Biotechnology. |
| What is the current market cap of Nakanishi? | Nakanishi's current market cap is $2B. |
| What is the current revenue of Nakanishi? | Nakanishi's last 12 months revenue is $547M. |
| What is the current revenue growth of Nakanishi? | Nakanishi revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Nakanishi? | Current revenue multiple of Nakanishi is 2.4x. |
| What is the current EBITDA of Nakanishi? | Nakanishi's last 12 months EBITDA is $135M. |
| What is Nakanishi's EBITDA margin? | Nakanishi's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Nakanishi? | Current EBITDA multiple of Nakanishi is 9.9x. |
| What is the current FCF of Nakanishi? | Nakanishi's last 12 months FCF is $40M. |
| What is Nakanishi's FCF margin? | Nakanishi's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Nakanishi? | Current FCF multiple of Nakanishi is 33.1x. |
| How many companies Nakanishi has acquired to date? | Nakanishi hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Nakanishi has invested to date? | Nakanishi hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Nakanishi
Lists including Nakanishi
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.